Skandinaviska Enskilda Banken (SEB)
RDY icon

Skandinaviska Enskilda Banken (SEB)’s Dr. Reddy's Laboratories RDY Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,800
Closed -$55.7K – 798
2024
Q1 		$55.7K Buy
+3,800
New +$55.5K ﹤0.01% 758

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RDY Position: Q2 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 3,800 shares — an estimated $55.7K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RDY in Q1 2024 and held it in 1 quarter. The position peaked at $55.7K in Q1 2024. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 3,800 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $55.7K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Dr. Reddy's Laboratories in Q1 2024 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Dr. Reddy's Laboratories position peaked at $55.7K in Q1 2024.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2024, filed 13 Aug 2024.